Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage

American Journal of Pathology

Volumn 174, Issue 6, 2009, Pages 2096-2106

  Yokoyama, Takeshi ^a   Kamijo Ikemori, Atsuko ^a   Sugaya, Takeshi ^a,b   Hoshino, Seiko ^a   Yasuda, Takashi ^a   Kimura, Kenjiro ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Strategic and Regulatory Affairs Consulting Department   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; FATTY ACID BINDING PROTEIN; FOLIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; INTERSTITIAL NEPHRITIS; KIDNEY PROXIMAL TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; URINARY EXCRETION;

EID: 67049132377     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080780     Document Type: Article

References (37)

1. Jacobson HR: Chronic renal failure: pathophysiology. Lancet 1991, 338:419-423
2. Bohle A, Mackensen-Haen S, von Gise H, Grund KE, Wehrmann M, Batz C, Bogenschutz O, Schmitt H, Nagy J, Muller C, Muller G: The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990, 186:135-144
3. Mackensen-Haen S, Bader R, Grund KE, Bohle A: Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin Nephrol 1981, 15:167-171 (Pubitemid 11104060)
4. Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T: Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 2007, 18:2894-2902 (Pubitemid 350058396)
5. Portilla D, Dent C, Sugaya T, Nagothu KK, Kundi I, Moore P, Noiri E, Devarajan P: Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008, 73:465-472 (Pubitemid 351186293)
6. Maatman RG, van de Westerlo EM, van Kuppevelt TH, Veerkamp JH: Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992, 288 (Pt 1):285-290
7. Maatman RG, Van Kuppevelt TH, Veerkamp JH: Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J 1991, 273 (Pt 3):759-766
8. Veerkamp JH, Peeters RA, Maatman RG: Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991, 1081:1-24
9. Sweetser DA, Heuckeroth RO, Gordon JI: The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of a function. Annu Rev Nutr 1987, 7:337-359
10. Negishi K, Noiri E, Maeda R, Portilla D, Sugaya T, Fujita T: Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 2008, 73:1374-1384 (Pubitemid 351770480)
11. Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M, Kumai T, Ohtani-Kaneko R, Hirata K, Kimura K: Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 2006, 169:1107-1117 (Pubitemid 351194349)
12. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, Honda A, Okabe M, Fujino T, Hirata Y, Omata M, Kaneko R, Fujii H, Fukamizu A, Kimura K: Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 2004, 165:1243-1255 (Pubitemid 39297730)
13. Kamijo-Ikemori A, Sugaya T, Kimura K: Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006, 374:1-7 (Pubitemid 44572240)
14. Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H: Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease. Am J Med Sci 2005, 330:161-165 (Pubitemid 41512989)
15. Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H: Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 2005, 28:2728-2732 (Pubitemid 43951167)
16. Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Koide H: Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria. Diabetes Metab Res Rev 2006, 22:385-389 (Pubitemid 44446434)
17. Yuan HT, Li XZ, Pitera JE, Long DA, Woolf AS: Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor- 1 alpha. Am J Pathol 2003, 163:2289-2301 (Pubitemid 37466473)
18. Fink M, Henry M, Tange JD: Experimental folic acid nephropathy. Pathology 1987, 19:143-149 (Pubitemid 17094215)
19. Byrnes KA, Ghidoni JJ, Mayfield ED Jr: Response of the rat kidney to folic acid administration. I. Biochemical studies. Lab Invest 1972, 26:184-190
20. Byrnes KA, Ghidoni JJ, Suzuki M, Thomas H, Mayfield ED Jr: Response of the rat kidney to folic acid administration. II. Morphologic studies. Lab Invest 1972, 26:191-200
21. Klingler EL Jr, Evan AP, Anderson RE: Folic acid-induced renal injury and repair. Correlation of structural and functional abnormalities. Arch Pathol Lab Med 1980, 104:87-93
22. Parchure M, Ambaye RY, Lalitha VS, Gokhale SV: Acute toxicity of folic acid in mice. Experientia 1985, 41:72-73 (Pubitemid 15163768)
23. Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, Numabe A, Takagi M, Hayakawa H, Tabei F, Sugimoto T, Mise N, Omata M, Kimura K: Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006, 284:175-182 (Pubitemid 44404425)
24. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, Hirata Y, Goto A, Omata M: Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease. J Lab Clin Med 2004, 143:23-30 (Pubitemid 38156413)
25. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, Hirata Y, Goto A, Fujita T, Omata M: Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 2002, 62:1628-1637 (Pubitemid 35286270)
26. Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K: Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid binding protein transgenic mice. Nephrol Dial Transplant 2009, 24:788-800
27. Kato Y, Mori Y, Makino Y, Morimitsu Y, Hiroi S, Ishikawa T, Osawa T: Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 1999, 274:20406-20414 (Pubitemid 129519519)
28. Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, Fujita T, Toda A, Yokomizo T, Kita Y, Kihara Y, Ishii S, Shimizu T, Noiri E: Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 2006, 168:1413-1424
29. Jarmi T, Agarwal A: Heme oxygenase and renal disease. Curr Hypertens Rep 2009, 11:56-62
30. de Haan JB, Bladier C, Griffiths P, Kelner M, O'Shea RD, Cheung NS, Bronson RT, Silvestro MJ, Wild S, Zheng SS, Beart PM, Hertzog PJ, Kola I: Mice with a homozygous null mutation for the most abundant glutathione peroxidase. Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide J Biol Chem 1998, 273:22528-22536
31. Schmidt AM, Yan SD, Yan SF, Stern DM: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001, 108:949-955 (Pubitemid 32946067)
32. Ueno Y, Horio F, Uchida K, Naito M, Nomura H, Kato Y, Tsuda T, Toyokuni S, Osawa T: Increase in oxidative stress in kidneys of diabetic Akita mice. Biosci Biotechnol Biochem 2002, 66:869-872 (Pubitemid 39251354)
33. Wang G, Gong Y, Anderson J, Sun D, Minuk G, Roberts MS, Burczynski FJ: Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology 2005, 42:871-879 (Pubitemid 41401125)
34. Ek-Von Mentzer BA, Zhang F, Hamilton JA: Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation. J Biol Chem 2001, 276:15575-15580 (Pubitemid 37391583)
35. Raza H, Pongubala JR, Sorof S: Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochem Biophys Res Commun 1989, 161:448-455 (Pubitemid 19162655)
36. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H: Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006, 47:439-444 (Pubitemid 43255177)
37. Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, Combe C, Moonen CW, Grenier N: Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 2003, 17:104-113